Search our blog


CEO and Cofounder Malcolm Kendall has over 28 years of operational management, entrepreneurial, venture capital investment and leadership experience, the majority of which has been focused on company creation and building value in technology and biotechnology companies. Before founding Microbiome Insights, he was the co-founder and CEO of Indel Therapeutics Inc., a Vancouver-based biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. Prior to this, Malcolm was an investment professional with life science focused venture capital firms MDS Capital (now Lumira Capital), BioVista Capital (now Hatteras Venture Partners) and Intersouth Partners. Before entering business, he served in the U.S. Army where he honed his leadership skills as an Infantry and Special Forces officer. Malcolm has been an advisor and board member to numerous companies and organizations and is currently a member of the board of directors of Semios BIO Technologies, a mentor for the entrepreneurship@UBC program and an adjunct professor at the MBA MOT program at Simon Fraser University. He received his undergraduate degree from Washington and Lee University and an M.B.A. from the Kenan-Flagler Business School at the University of North Carolina.

Entries by Malcolm Kendall

Microbiome Conferences in 2024

Every year, we compile an extensive list of both in-person and online microbiome conferences from around the world. These events cover all aspects of the microbiome, from basic science, R&D, and commercialization to applications in human, animal, plant, environmental, gut, skin, oral health, and...

Read more

Team Insights: Sarah Carden

Welcome back to Team Insights, where we offer you a chance to get to know a Microbiome Insights team member on a deeper level. For our newest issue of Team Insights, we bring in a new member of our Sales Team: Sarah Carden. We're excited to welcome Sarah into the Microbiome Insights team, and...

Read more

Happy International Women's Day from Microbiome Insights

At Microbiome Insights, we're proud of the women on our team who help us do what we do. It's important to us that we recruit only the best and most driven individuals -- and we are proud that more than 40% of our employees and leaders are women. 

Read more

Microbiome Insights' Year in Review: 2017 by the numbers

This year, 2017, will go down in Microbiome Insights history as the year the company hit its stride and established itself as a leader in the microbiome testing field. The challenging work our team has been doing since we were founded in 2015 clearly paid off—as evidenced by our expanding client...

Read more

How close are microbiome-modulating therapies that target the brain? A quick overview of the evidence

Debate exists about how soon knowledge about the gut-brain axis will bear fruit. Yet the microbiome-gut-brain axis is a hot topic of scientific investigation and several companies around the globe are actively pursuing gut microbiome therapies that focus on brain-related conditions.

Read more


We create content to support you with your microbiome research.